Related Experiment Video
Updated: Jul 14, 2026

Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Premature infants: analysis of serum phosphate during the first 4 weeks of life
Nahed El Hassan1, Rita Ryan, Laroia Nirupama
1Department of Pediatrics, Division of Neonatology, College of Medicine, University of Arkansas Medical School, Arkansas Children's Hospital, Little Rock, Arkansas, USA.
Insights
This study established phosphate norms for premature infants (500-1500g) during their first month. Lower phosphate levels were observed in lower birthweight neonates, suggesting potential use as an acuity marker.
Area of Science:
- Neonatal Medicine
- Pediatric Endocrinology
- Biochemistry
Background:
- Accurate phosphate level monitoring is crucial for neonatal care.
- Establishing normative data for premature infants is essential for early detection of metabolic disturbances.
Purpose of the Study:
- To establish phosphate reference ranges for neonates with birthweights between 500 and 1500 grams during the first four weeks of life.
- To compare phosphate levels between neonates in different birthweight categories (500-1000g vs. 1001-1500g).
Main Methods:
- Prospective study involving 52 neonates divided into two birthweight groups (A: 500-1000g, B: 1001-1500g).
- Daily phosphate level measurements from day 1 to 5, followed by weekly measurements until week 4.
- Statistical analysis to compare phosphate levels between the two groups.
Main Results:
- Phosphate levels were generally lower in the lower birthweight group (Group A) compared to the higher birthweight group (Group B).
- This difference was statistically significant, excluding the first two days of life.
- Normative phosphate data were generated for the first four weeks of life in this cohort.
Conclusions:
- The study provides initial phosphate norms for low birthweight neonates.
- Lower phosphate levels in very low birthweight infants may indicate specific metabolic needs or risks.
- Further research is warranted to explore phosphate as a marker of neonatal acuity and the impact of phosphate repletion.
Abstract:
The purpose of this study was to establish phosphate norms for the first 4 weeks of life for neonates with birthweight (BW) 500 to 1500 g. The study group included 52 consecutively born neonates: group A (n = 24; BW 500 to 1000 g), and group B (n = 28; BW 1001 to 1500 g). Phosphate levels are reported daily (days 1 to 5), and then weekly until week 4. Except for the first 2 days of life, phosphate levels were statistically lower in group A versus group B. A prospective study is required to examine whether phosphate levels can be used as a marker of acuity in neonates and to examine the effect of phosphate repletion on metabolic functions.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Introduction to Electrolytes
Role of Sodium
One...

